Dnd Technologies (DNDT)
DND Technologies, Inc. is a common stock listing on OTC Markets under the symbol DNDT. The company operates as a holding company focused on specialty balms and pharmaceutical-related products. Its product line includes Bioassaygen Gel, which is described as helping reduce wrinkles and support natural skin re-genesis, along with Bioassaygen Cosmetic Mask for vanity use, Bioassaygen Bio-Skin as a skin replacement bandage, and Bioassaygen Delivery Gel intended to accelerate natural skin re-genesis. DND Technologies distributes its products through wholesale, retail, and Internet channels. Founded in 1997, the company is based in New York, New York.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-DNDT
|
—
|
—
|
—
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
1.679 M
|
—
|
—
|
—
|
—
|
—
|
—
|